<DOC>
	<DOCNO>NCT01397903</DOCNO>
	<brief_summary>The purpose assess response add-on therapy , base CGI-I scale , 4 week , patient MDD inadequate disease control antidepressant medication .</brief_summary>
	<brief_title>Description Treatment Management Patients With Major Depressive Disorder Inadequate Response</brief_title>
	<detailed_description>A cross-sectional observational study describe treatment management patient Major Depressive Disorder ( MDD ) inadequate response antidepressant Greece</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Diagnosis MDD per DSMIV Patients inadequate disease control antidepressant therapy Patients already receive addon therapy complete 45 week treatment time enrolment study . Patients fulfil criterion diagnosis psychiatric condition ( except MDD ) , per DSMIV Axis I , Concomitant organic mental disorder mental retardation Substance abuse dependence ( exception nicotine dependence ) , define DSMIV criterion Participation another study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>antidepressant therapy , inadequate control , add-on therapy</keyword>
</DOC>